MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

134.91 +2.86 (+2.17%)
Streaming Delayed Price Updated: 10:33 AM EDT, Apr 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about State Street SPDR S&P Biotech ETF

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
News headline image
The Bear Market Is Already Here – But Not For Dividend Investors ↗
While the broad stock market indices remain at near-record levels, there are sectors of the market that have dropped into correction or even bear market territory over recent months. 
Via Talk Markets
News headline image
Biotech Playbook 2021 Part 2: Rotation Rally Brings Relief after FED Pivot ↗
The new aggressive Fed taper combined with a rise in interest rates for 2022 adds a new element of risk to portfolio management. Monetary policy is a headwind for 2022. 
Via Talk Markets
News headline image
10 Bargain Stocks to Buy After Falling 30% in 2021 ↗
If you’re looking for bargain stocks to buy that are down 30% or more in 2021, that’s not an easy task. Here are 10 that fit the bill. 
Via InvestorPlace
News headline image
Biotech Playbook 2021: No Help From Small Caps In Q4 ↗
Mid-cap stock picks have done better today but are way off their 2021 highs. Cryoport and Veracyte are still up and look better technically. Quidel was up 5.48% today on Omicron concerns globally but... 
Via Talk Markets
Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity ↗
SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) shares... 
Via Benzinga
Topics Stocks
Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity ↗
SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) shares... 
Via Benzinga
Topics Stocks
Unusual Options Activity Insight: SPDR Series Trust SPDR S&P Biotech ETF ↗
On Friday, shares of SPDR Series Trust SPDR S&P Biotech ETF (NYSE: 
Via Benzinga
Topics Stocks
News headline image
8 Monster Stock Market Predictions – The Week Of December 13, 2021 Edition ↗
Via Talk Markets
News headline image
5 Top-Ranked ETFs to Buy At Bargain Prices ↗
The beaten-down prices have charged up investors to snap up ETFs on the cheap. Investors could definitely look to these products for outsized gains over the longer term. 
Via Talk Markets
News headline image
How Did Healthcare Stocks Perform Over This Volatile Month? ↗
It’s been a rough month for small-cap biotech stocks amidst a general correction in the market which brought general indices down about 10%. 
Via Talk Markets
News headline image
Tuesday Talk: O(micron) - Pow(ell)! ↗
As Wall St. investors await the market open Tuesday, futures dive on Omicron concerns as well as anticipation surrounding Yellen and Powell's Senate testimony this morning. 
Via Talk Markets
News headline image
Stocks Rise On November 29 On Predictable Volatility Crush ↗
Stocks jumped on November 29 as volatility came down sharply. 
Via Talk Markets
Understanding SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity ↗
Shares of SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI 
Via Benzinga
Topics Stocks
Unusual Options Activity Insight: SPDR Series Trust SPDR S&P Biotech ETF ↗
SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) shares... 
Via Benzinga
Topics Stocks
News headline image
COVID Is Back Disrupting Markets And Causing More Sector Uncertainty ↗
Just when you were having an enjoyable four day weekend cruising along the interminable bull market COVID is back disrupting trends. Healthcare stocks held up reasonably well .Will there be new respect... 
Via Talk Markets
News headline image
Biotech Stocks are Due for a Rally ↗
There are many rebalancing trades left in your stock portfolio but biotech is in the doldrums. 
Via Talk Markets
News headline image
Looking for Growth in Small and Mid Cap Life Science Stocks ↗
2021 is an unusual year for biotech with a “blow-off” February high in speculative small caps. 
Via Talk Markets
News headline image
How Are Biotech ETFs Reacting To These Q3 Earnings Releases? ↗
There's no denying that the pandemic has opened up investment opportunities in the biotech sector by triggering a race to introduce vaccines. Let’s take a look at big biotech earnings releases to see... 
Via Talk Markets
News headline image
Wednesdays With Wedbush On PreMarket Prep Plus ↗
On the PreMarket Prep Plus "Wednesday’s With Wedbush" segment, Sahak Manuelian, managing director and head of equi... 
Via Benzinga
News headline image
15 Charts All Traders Should Look At Every Morning ↗
One of the hardest things to do as a day trader is gathering all the necessary information to execute profitable trades. Below are the to... 
Via Benzinga
News headline image
Look For The Q4 Biotech Bounce In Mid-Small Caps ↗
Large-cap biopharma stocks are off their highs because of prospects that drug prices may be directly negotiated through Medicare but several Democrats are not in agreement as to how this could be best... 
Via Talk Markets
News headline image
Small Cap Biotechs Sagging But More Deals Are Likely to Perk Up the Market ↗
Despite record highs in the Nasdaq recently at the 15,000 level the biotech market seems sluggish. Speculation has ebbed. As if we need a green screen every day. 
Via Talk Markets
News headline image
Healthcare Stocks Hit New Highs but Small Caps Lag ↗
Many smaller cap biotech stocks trade on news and milestones and have no earnings so require more expertise in the field. 
Via Talk Markets
News headline image
ETF Reflections: US Stocks ↗
I'm a bear. So the longer they prop this dreck up, the greater the fall. Suits me! 
Via Talk Markets
News headline image
Biotech ETFs To Benefit From Latest Booster Update ↗
Vaccine makers like Moderna and Pfizer have reasons to cheer the update with regard to the application of boosters. The U.S. government announced plans to make COVID-19 vaccine boosters available from... 
Via Talk Markets
News headline image
Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity ↗
On Monday, shares of SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) saw unusual options activity. After the option alert, the stock price moved down to $122.44. Sentiment... 
Via Benzinga
Topics Stocks
News headline image
Large Cap Biopharma Stocks provide Growth and Value ↗
The S&P 500 Healthcare Index was up 0.53% and biotech still lags in healthcare yet Large Cap Biopharma is doing well YTD. 
Via Talk Markets
Topics Stocks
News headline image
ETF Investing Areas to Consider for August ↗
There is no doubt that the second-quarter 2021 earnings season is going strong. 
Via Talk Markets
News headline image
Carter Worth And Mike Khouw's XBI Trade ↗
On CNBC's "Options Action," Carter Worth of Cornerstone Macro said SPDR S&P Biotech ETF (NYSE: XBI) has a bounce potential, having sold off to support. XBI is an... 
Via Benzinga
Topics Stocks
News headline image
Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity ↗
Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity Shares of SPDR Series Trust SPDR S&P Biotech ETF (NYSE: XBI) saw some unusual options activity... 
Via Benzinga
Topics Stocks
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story